Lyell Immunopharma Inc (LYEL) Stock Price

12.39 ▼ -0.61 (-4.69%)
Open: 13.21 Vol: 0 Day's range: 12.39 - 13.87 Jun 25, 15:21 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
LYEL Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 12.41▼ 12.54▼ 12.62▼ 12.55▼ 13.59▼
MA10 12.46▼ 12.79▼ 12.90▼ 12.85▼ 16.59▼
MA20 12.57▼ 12.97▼ 12.83▼ 13.52▼ 19.36▼
MA50 12.91▼ 12.60▼ 12.63▼ 17.62▼ 19.08▼
MA100 12.97▼ 12.73▼ 12.77▼ 20.13▼ 17.61▼
MA200 12.60▼ 12.76▼ 14.61▼ 20.78▼ 37.52▼
  5 mins 30 mins Hourly Daily Weekly
MACD -0.003▼ -0.111▼ -0.070▼ 0.184▲ -1.171▼
RSI 23.643▼ 38.152▼ 42.224▼ 36.178▼ 35.669▼
STOCH 3.277▼ 3.435▼ 15.405▼ 34.807     11.544▼
WILL %R -98.113▼ -99.663▼ -99.663▼ -70.850     -94.611▼
CCI -90.237     -113.195▼ -151.749▼ 12.317     -112.840▼
Latest Filters Detected On LYEL
MA $LYEL Price Crossed Below MA(13) Set Alert
MA $LYEL Price Crossed Below MA(7) Set Alert
CDL $LYEL Evening Star Candlestick Pattern Detected Set Alert
CDL $LYEL Engulfing Candlestick Pattern Detected Set Alert
Lyell Immunopharma Inc News
Lyell Immunopharma Announces Participation in H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
Thursday, June 25, 2026 05:18 AM
Lyell Immunopharma, Inc. (Nasdaq: LYEL), a late-stage clinical company advancing a pipeline of next-generation chimeric antigen receptor (CAR) T-cell therapies for patients with cancer, today ...
Lyell Immunopharma Announces Participation in H.C. Wainwright 4th Annual Cell Therapy Virtual ...
Thursday, June 25, 2026 05:00 AM
Lyell Immunopharma, Inc. (Nasdaq: LYEL), a late-stage clinical company advancing a pipeline of next-generation chimeric antigen receptor (CAR) T-cell therapies ...
Lyell Immunopharma Presents Updated Safety Data and Translational Insights for Rondecabtagene Autoleucel (Ronde-Cel) in Patients with Large B-Cell Lymphoma at European ...
Friday, June 12, 2026 11:44 AM
More than 100 patients treated with ronde-cel in 2L and 3L+ LBCL, with a manufacturing success rate of 97%No Grade ≥ 3 CRS and low rates of Grade ≥ 3 ICANS, supporting outpatient ...
LYEL historical stock data
date open high low close volume
25/06/26 13.21 13.87 12.385 12.39 87,576
24/06/26 12.65 13.25 12.3501 13.00 132,420
23/06/26 11.88 13.02 11.86 12.63 151,975
22/06/26 12.84 13.06 11.67 11.97 184,335
18/06/26 12.73 13.22 12.245 12.74 357,682
17/06/26 12.48 13.02 12.345 12.52 161,500
16/06/26 13.36 13.47 12.03 12.44 198,602
15/06/26 13.78 13.955 13.27 13.55 82,425
12/06/26 13.67 13.80 13.08 13.50 96,428
11/06/26 13.22 14.14 12.83 13.72 142,506
Quote Details
52wk Low:8.632
52wk High:45.00
Vol:0
Avg Vol(3m):2M
1Y Chng:+28.13%
1M Chng:-35.60%
Add to Watch List
More Information
Index US Composite
Market Cap. 294.71M